T Twenty-one scientists from five UC campuses are partnering with the Mosquito and Vector Control Association of California to defeat one of the world's oldest and deadliest diseases: malaria.
Malaria infects some 350 to 500 million people a year, killing between 1 million and 2.5 million, according to the World Health Organization. Ninety percent of the global incidence of malaria occurs in Africa, where a child dies from the disease every 30 seconds.
The "This is all about saving lives," Lanzaro says. "It's the right thing to do. We are combining compassion, technology and science to defeat a killer."
Malaria, first recognized 4,000 years ago and eradicated in the United States in the early 1950s, has been eliminated in many parts of Asia, Europe and the Americas, but is raging uncontrolled in many parts of Africa, Lanzaro says. "The spike can be attributed to more efficient mosquito vectors, increased pesticide and drug resistance, and socioeconomic factors, including struggling health systems."
Malaria threatens more than 100 countries and territories, with more than 40% of the world's population at risk, according to the U.S. Centers for Disease Control and Prevention. Children under age 5 and pregnant women are most susceptible.
UC Davis scientist recounts battle with neuroinvasive West Nile virus
"Keira's blood test proved strongly positive for the West Nile virus," said CVEC research entomologist William Reisen, who researches Culex mosquitoes.
Looking back, Simmons speculates that the infected mosquito bit her when she and her fiancé were hiking along Putah Creek on the UC Davis campus.
Hospital technicians drew her blood, but Simmons learned later that it was never tested for West Nile virus, even though she had repeatedly asked for the test. "They ran a few noninvasive tests and some cultures. When none of them was conclusive, they simply gave me IV fluids and sent me home. They said I had the flu."
The illness alarmed her family and friends. "No one around me had been sick and no one was getting sick from exposure to me. It was quite frightening for my A strange red rash splotched her inner arms and torso. Within 4 days, the rash covered her entire body, even between her fingers and toes. A knife-splitting headache, coupled with crushing muscle pain, vomiting, neck stiffness, fatigue, dizziness and nausea ensued.
Her normal 98.5°F degree temperature spiked to 102°F and then raged to 106.5°F. She dropped 20 pounds in 10 days.
The UC Davis scientist remembers four trips to the hospital emergency room, a 3-day hospitalization to treat the raging fever, worsening pain, dizziness and dehydration, and a 3-week recovery period at home. The illness incapacitated her for 7 weeks.
It nearly killed her. "The doctors thought I had the flu," recalls Simmons, then 27 and a postgraduate researcher in a UC Davis School of Medicine lab.
It was not the flu. Only after she had accepted a research position in November 2005 at the UC Davis Center for Vectorborne Diseases (known as CVEC), did a routine blood test confirm her worst suspicions: neuroinvasive West Nile virus , the most severe virus spread by Culex mosquitoes. mom, dad, sister and fiancé to stand by, powerless, and watch me deteriorate."
When her personal physician admitted her to the hospital, "I wasn't real aware of my surroundings or what was going on at that time. I had literally started to mentally check out," she says. "I was quite fortunate that I had my fiancé, family and my physician advocating on my behalf."
Today side effects still persist. "I feel generally healthy," Simmons says, "but I still have about three or four headaches of migraine-intensity a week. I also still have some weakness in my arms and hands, affecting my manual dexterity. I have transient spells of vertigo that leave me unable to work in my capacity as a researcher." "I have no idea when these symptoms will resolve. West Nile virus is so new to our population that they really don't have any idea how it may affect people or their quality of life."
Since her encounter with the infected mosquito, Simmons works with a renewed interest as a researcher and the lead molecular technician at CVEC, testing mosquito pools and dead bird tissue submitted from throughout the state.
Had she not changed jobs and taken the mandatory blood test, Simmons believes the disease may have gone undiagnosed. Her reaction to the positive blood test? "Vindicated. Validated. I knew there was something seriously wrong with me."
-Kathy Keatley Garvey
Lanzaro, who researches Anopheles gambiae, the principal vector of malaria in Africa, says the most deadly parasite is Plasmodium falciparum. It can kill within hours of noticeable symptoms, which include high fever, severe headache, drowsiness, delirium and confusion. The malaria mosquitoes bite at night, usually between 10 p.m. and 4 a.m.
Focus on research and education
At its organizational meeting in May 2006, MRCG agreed to focus on academic research, education and public service. Its mission is threefold: facilitate collaborative activities, including organized research and training; mitigate the malaria burden in Africa; and provide technical advice to public health agencies on malaria control programs, based on mosquito abatement in Africa.
Individual members of MRCG are involved in eight African partnerships and two researchtraining grants.
Basic researchers study mosquito molecular genetics, population genomics and the ecology of malaria vectors, mosquito mating biology, and the genetics of immunology and biochemistry of A.gambiae/P. falciparum interactions.
Applied research involves the evaluation of existing insecticide-based control strategies, the development of novel mosquito attractants, new assays for the detection of metabolic insecticide resistance in mosquitoes, the role of agricultural insecticide use in the development of resistance in mosquitoes, the mass-rearing of A. gambiae, and models for malaria associated with rice agriculture.
Lanzaro and UC Davis medical entomologist Anthony Cornel of the UC Mosquito Research Laboratory, located at the Kearney Agricultural Center in Parlier, have conducted fieldwork in Africa for more than 15 years, zeroing in on insecticide and drug resistance and population genetics. Last summer, medical entomologist Shirley Luckhart, a UC Davis School of Medicine faculty member, and entomology graduate students Tara Thiemann and Lisa Reimer joined them in Mali. Cornel, a native of South Africa, and Thiemann also worked in Cameroon last summer.
Funded by a National Institutes of Health grant, Lanzaro is researching the complex genetic structure of A. gambiae. "Using DNA markers we have been able to demonstrate that subpopulations of this mosquito exist in nature that do not interbreed and therefore do not exchange genes," Lanzaro says. "These subpopulations often exist even within a single village. This has important 
